Literature DB >> 27057793

p53 family members regulate cancer stem cells.

Subhasree Basu1, Maureen E Murphy1.   

Abstract

Entities:  

Keywords:  p53; p73; stem cells; ΔN-p73

Mesh:

Substances:

Year:  2016        PMID: 27057793      PMCID: PMC4934078          DOI: 10.1080/15384101.2016.1171649

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.

Authors:  Varun V Prabhu; Bo Hong; Joshua E Allen; Shengliang Zhang; Amriti R Lulla; David T Dicker; Wafik S El-Deiry
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

2.  Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures.

Authors:  Hideaki Mizuno; Benjamin T Spike; Geoffrey M Wahl; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

3.  Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.

Authors:  Avinashnarayan Venkatanarayan; Payal Raulji; William Norton; Elsa R Flores
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 4.  Unravelling cancer stem cell potential.

Authors:  Benjamin Beck; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

5.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

6.  Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.

Authors:  Bo Hong; Varun V Prabhu; Shengliang Zhang; A Pieter J van den Heuvel; David T Dicker; Levy Kopelovich; Wafik S El-Deiry
Journal:  Cancer Res       Date:  2013-11-18       Impact factor: 12.701

7.  p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.

Authors:  Claudia Meier; Philip Hardtstock; Sophie Joost; Vijay Alla; Brigitte M Pützer
Journal:  Cancer Res       Date:  2015-11-10       Impact factor: 12.701

  7 in total
  5 in total

1.  Integrin-β4 is a novel transcriptional target of TAp73.

Authors:  Ningxia Xie; Polina Vikhreva; Margherita Annicchiarico-Petruzzelli; Ivano Amelio; Nicolai Barlev; Richard A Knight; Gerry Melino
Journal:  Cell Cycle       Date:  2018-02-08       Impact factor: 4.534

Review 2.  Regulation of Adult Neurogenesis in Mammalian Brain.

Authors:  Maria Victoria Niklison-Chirou; Massimiliano Agostini; Ivano Amelio; Gerry Melino
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

3.  A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.

Authors:  Thibault Voeltzel; Mario Flores-Violante; Florence Zylbersztejn; Sylvain Lefort; Marion Billandon; Sandrine Jeanpierre; Stéphane Joly; Gaelle Fossard; Milen Milenkov; Frédéric Mazurier; Ali Nehme; Amine Belhabri; Etienne Paubelle; Xavier Thomas; Mauricette Michallet; Fawzia Louache; Franck-Emmanuel Nicolini; Claude Caron de Fromentel; Véronique Maguer-Satta
Journal:  Cell Death Dis       Date:  2018-09-27       Impact factor: 8.469

4.  TAp73 regulates ATP7A: possible implications for ageing-related diseases.

Authors:  Piervito Lopriore; Nazzareno Capitanio; Emanuele Panatta; Nicola Di Daniele; Alessandra Gambacurta; Gerry Melino; Ivano Amelio
Journal:  Aging (Albany NY)       Date:  2018-12-08       Impact factor: 5.682

5.  Emodin promotes the arrest of human lymphoma Raji cell proliferation through the UHRF1‑DNMT3A‑∆Np73 pathways.

Authors:  Yun Lin; Weiming Chen; Zhihong Wang; Pengwei Cai
Journal:  Mol Med Rep       Date:  2017-09-05       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.